Scientific Publications

SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma

G.J.J.E. Heynen
F. Baumgartner
M. Heider
U. Patra
M. Holz
J. Braune
M. Kaiser
I. Schäffer
S.A. Bamopoulos
E. Ramberger
A. Murgai
Y.L.D. Ng
U.M. Demel
D. Laue
S. Liebig
J. Krüger
M. Janz
A. Nogai
M. Schick
P. Mertins
S. Müller
F. Bassermann
J. Krönke
U. Keller
M. Wirth

Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase in B cell lymphomas

C. Lopez
N. Schleussner
S.H. Bernhart
K. Kleinheinz
S. Sungalee
H.L. Sczakiel
H. Kretzmer
U.H. Toprak
S. Glaser
R. Wagener
O. Ammerpohl
S. Bens
M. Giefing
J.C.G. Sanchez
G. Apic
D. Hubschmann
M. Janz
M. Kreuz
A. Mottok
J.M. Müller
J. Seufert
S. Hoffmann
J.O. Korbel
R.B. Russell
R. Schule
L. Trumper
W. Klapper
B. Radlwimmer
P. Lichter
R. Kuppers
M. Schlesner
S. Mathas
R. Siebert

A peculiar case of primary central nervous system T-cell lymphoma with indolent behavior

D. Wasilewski
M. Janz
A. Koch
A. Rosenwald
U. Keller
P. Vajkoczy
K. Faust
I. Anagnostopoulos
J. Radke

Differentiation of cerebral neoplasms with vessel size imaging (VSI)

A. Foda
E. Kellner
A. Gunawardana
X. Gao
M. Janz
A. Kufner
A.A. Khalil
R. Geran
R. Mekle
J.B. Fiebach
I. Galinovic

February 17, 2022 in N Engl J Med

Second-line tisagenlecleucel or standard care in aggressive B-cell lymphoma

M.R. Bishop
M. Dickinson
D. Purtill
P. Barba
A. Santoro
N. Hamad
K. Kato
A. Sureda
R. Greil
C. Thieblemont
F. Morschhauser
M. Janz
I. Flinn
W. Rabitsch
Y.L. Kwong
M.J Kersten
M.C. Minnema
H. Holte
E.H.L. Chan
J. Martinez-Lopez
A.M.S. Müller
R.T. Maziarz
J.P. McGuirk
E. Bachy
S. Le Gouill
M. Dreyling
H. Harigae
D. Bond
C. Andreadis
P. McSweeney
M. Kharfan-Dabaja
S. Newsome
E. Degtyarev
R. Awasthi
C. Del Corral
G. Andreola
A. Masood
S.J. Schuster
U. Jäger
P. Borchmann
J.R. Westin

Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals

S. Denker
A. Bittner
M. Frick
J. Kase
J. Hoffmann
C. Trenker
U. Keller
C. Bogner
A. Hüttmann
J. Dürig
M. Janz
S. Mathas
R. Marks
U. Krohn
I.K. Na
L. Bullinger
C.A. Schmitt

Graded elevation of c-Jun in Schwann cells in vivo: gene dosage determines effects on development, remyelination, tumorigenesis, and hypomyelination

S.V. Fazal
J.A. Gomez-Sanchez
L.J. Wagstaff
N. Musner
G. Otto
M. Janz
R. Mirsky
K.R. Jessen

Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012)

N. Baras
S. Dahm
J. Haberland
M. Janz
K. Emrich
K. Kraywinkel
A. Salama

Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma

K.D. Wurster
F. Hummel
J. Richter
M. Giefing
S. Hartmann
M.L. Hansmann
S. Kreher
K. Köchert
D. Krappmann
W. Klapper
M. Hummel
S.S. Wenzel
G. Lenz
M. Janz
B. Dörken
R. Siebert
S. Mathas